09 May Can Mental Health Parity Laws Ensure Access to Psychedelic Assisted Therapy?
This week, the company formerly known as MAPS PBC—Lykos Therapeutics—announced that the FDA will start the review process for MDMA-Assisted Therapy in June. From the Lykos Press Release:on June 4, 2024, the U.S. Food and Drug Administration’s (“FDA”) Psychopharmacologic Drugs Advisory Committee (“PDAC”) will review data...